Company
Every investor coverage indicates participated in a round ARC raised.
Companies ARC acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming ARC. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian nanobiotech firm Nexsen has begun trading on the sharemarket after an $8m IPO; earlier government grants and an RMIT research collaboration are also noted.
RenewEconomy reports HB11 Energy's bilateral research deal with Spanish laser labs and mentions its earlier $560,000 grant from ARC for a fusion laser project with UNSW and other universities.
Horizon 3 Biotech, an Australian life sciences venture fund, announces Dr Tam Nguyen joining its investment committee, citing his board, research commercialisation and healthcare experience and past Brandon Capital secondment.